PV Bulletin
PvBulletin

Tag archive

GxP

AI/GxPFdaUnited Kingdom

MHRA updates SaMD/AIaMD guidance, highlighting PCCP and transparency principles

Relevant for
Signal Management LeadRegulatory Intelligence LeadMedical Device Vigilance LeadPV Quality Lead+2 more
Action needed

Ask the safety/device vigilance and PV CSV leads to: (1) confirm whether any marketed/fielded SaMD/AIaMD uses adaptive ML or planned updates that would fit a PCCP-like approach; (2) review current change-control SOPs and technical documentation to ensure change governance and transparency artifacts are captured and retrievable; (3) verify post-market/vigilance processes explicitly account for algorithm updates (e.g., monitoring after updates, escalation criteria).

Process impact
Risk ManagementDevice VigilanceInspection Readiness
SOP impact

5 SOPs may need review

Urgency: HighConfidence: medium
Read impact brief
AI/GxPEma

MHRA reiterates GxP data integrity spans GVP as Annex 11 evolves

Relevant for
QPPVLocal Safety OfficerSignal Management LeadRegulatory Intelligence Lead+3 more
Action needed

Ema update requires triage for Local Affiliate Compliance, Vendor Oversight, Inspection Readiness; confirm local obligations and document follow-up actions.

Process impact
Local Affiliate ComplianceVendor OversightInspection Readiness
SOP impact

7 SOPs may need review

Urgency: HighConfidence: medium
Read impact brief

Get updates for your PV role

Subscribe to receive impact-first pharmacovigilance updates tailored by role and workflow.

Current context: role Signal Management Lead, workflow All.